Singapore Oral Contraceptives Market Report 2022 to 2030

Singapore Oral Contraceptives Market Analysis

$ 3999

Singapore oral contraceptives market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growth drivers for the market are raising awareness of the advantages of oral contraceptives, increasing the proportion of women working, increasing the number of sexually transmitted diseases (STIs), increasing the usage of reversible long-acting contraception (LARCs), Increasing the number of internet pharmacies. Some of the major key players in this market are Allergan plc, Bayer AG, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., etc.

ID: IN10SGPH351 CATEGORY: Pharmaceuticals GEOGRAPHY: Singapore AUTHOR: Saloni Shah

Buy Now

Singapore Oral Contraceptives Market Analysis Summary

Singapore Oral Contraceptives Market is valued at around $21 Mn in 2022 and is projected to reach $34.6 Mn by 2030, exhibiting a CAGR of 6.45% during the forecast period 2023-2030.

One of the most widely used forms of contraception by women worldwide is oral contraceptives, also known as birth control tablets or simply "the pill." This pharmaceutical advancement has significantly improved the reproductive health of women by giving them a safe and practical method of avoiding pregnancy. Oral contraceptives are made of synthetic hormones, usually an estrogen and progestin combination or just progestin. Together, these hormones limit ovulation and the release of an egg from the ovary. Additionally, they thin the uterine lining, which makes it less responsive to implantation, and thicken the cervical mucus, which makes it difficult for sperm to reach the uterus. Less than one in 100 women who use oral contraceptives as directed will become pregnant unintentionally within a year of regular use, indicating the excellent efficacy rate of these methods. It is important to remember, nevertheless, that continuous, appropriate use is needed for maximum results. Growth drivers for the oral contraceptive market are raising awareness of the advantages of oral contraceptives, increasing the proportion of women working, increasing the number of sexually transmitted diseases (STIs), increasing the usage of reversible long-acting contraception (LARCs), and increasing the number of internet pharmacies. The major key players in this market are Allergan plc, Bayer AG, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Piramal Enterprises, Syzygy Healthcare LLC.

Market Dynamics

Market Growth Drivers

During the projection period, it is projected that the introduction of programs aimed at lowering unintended pregnancies and the associated healthcare expenses as well as raising user awareness levels will fuel market growth. Additionally, the rise in unwanted pregnancies is anticipated to aid in the market's expansion throughout the projected year.

Market Restraints

Many women may find the expense of oral contraceptives to be a barrier, especially those who live in underdeveloped or low-income areas. Access to these contraceptives may be hampered by a lack of insurance coverage or high out-of-pocket costs, which would restrict their market. Moreover, side effects and health concerns can hamper the growth of the market.

Competitive Landscape

Key Players

Allergan Plc
Bayer AG
Johnson & Johnson Services, Inc.
Mankind Pharma Ltd.
Merck & Co., Inc.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Piramal Enterprises
Syzygy Healthcare LLC

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Singapore Oral Contraceptives Market Segmentation

By Type

Combination
Monophasic
Triphasic
Others
Progestin Only
Others

By Category

Generic
Branded

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.